Join

Press Releases

Delayed 3m

Fastest customizable press release feed in the world.

Signed out · 3-min delay · Sign up for real-time

  • OS Therapies Incorporated logo
    PR··Health Care·
    OS Therapies Achieves Global Regulatory Alignment on Design of Phase 3 Trial of OST-HER2 in Fully Resected, Pulmonary Metastatic Osteosarcoma

    Confirmatory Phase 3 trial to commence prior to BLA grant under Accelerated Approval Program in the U.S. and Conditional MAA in the U.K., Europe and AustraliaPatent pending pharmacodynamic response biomarker accepted as surrogate clinical efficacy endpointTGA and MHRA agree to allow utilization of remaining Phase 2b drug product for initiation of confirmatory Phase 3FDA and EMA fully align with Company on Chemistry, Manufacturing and Controls (CMC)Market access process initiated with UK NICE and EU JCANew York, New York and Rockville, Maryland--(Newsfile Corp. - June 8, 2026) - OS Therapies, Inc. (NYSE:OSTX) ("OS Therapies" or "the Company"), the world leader in gene-edited, Listeria-based c

  • Honeywell International Inc. logo
    PR··Industrials·
    HONEYWELL REAFFIRMS 2026 OUTLOOK AHEAD OF HONEYWELL AEROSPACE SPIN-OFF; INITIATES 2026 OUTLOOK FOR HONEYWELL TECHNOLOGIES

    CHARLOTTE, N.C., June 8, 2026 /PRNewswire/ -- Honeywell (NASDAQ:HON) today announced it was reaffirming its full-year 2026 guidance ahead of the planned Honeywell Aerospace spin-off on June 29, 2026. The company also provided a preliminary 2026 outlook for the remaining company post spin, which will conduct business under the name Honeywell Technologies. The company will discuss its latest outlook for 2026 during an investor conference call starting at 8:30 a.m. Eastern Daylight Time today, which precedes its 2026 Investor Day on June 11, 2026. 2026 OutlookHoneywell continues to expect sales of $38.8 billion to $39.8 billion with organic1 sales growth in the range of 3% to 6%. Segment margin

  • Gamehaus Holdings Inc. logo
    PR··Technology·
    Gamehaus Holdings Inc. Announces Unaudited Financial Results for the Third Quarter of Fiscal 2026 Ended March 31, 2026

    SHANGHAI, June 8, 2026 /PRNewswire/ -- Gamehaus Holdings Inc. ("Gamehaus" or the "Company") (NASDAQ:GMHS), a technology-driven mobile game publisher, today announced its unaudited financial results for the third quarter of fiscal year 2026 ended March 31, 2026. Third Quarter of Fiscal Year 2026 Financial HighlightsTotal revenue was US$26.2 million, representing a 9.1% decrease from US$28.8 million in the third quarter of fiscal year 2025. In-app purchases contributed US$23.4 million, while advertising revenue reached US$2.8 million.Total operating costs and expenses were US$25.7 million, representing a 10.1% reduction from US$28.5 million in the third quarter of fiscal year 2025.Net income w

  • Solidion Technology Inc. logo
    PR··Miscellaneous·
    Solidion Technology Granted 7 New Patents on Composite Anode Materials For Batteries Targeting Humanoid Robots, Space-Based Artificial Intelligence Data Centers and the Lunar Economy

     The newly granted patents further strengthen an already globally leading portfolio of patents on anode materials for high-energy and fast-charging lithium batteriesDALLAS, June 8, 2026 /CNW/ -- Solidion Technology Inc. ("Solidion" or the "Company") (NASDAQ:STI), an advanced battery technology solutions provider, today announced the grant of 7 new US patents, bringing the Company's IP portfolio to the total of 130 US patents alone on anode materials for lithium batteries. Solidion's silicon anode is engineered to (i) deliver a longer uptime for AI data centers on the ground or in the space; (ii) extend the flying range of an un

  • Yalla Group Limited logo
    PR··Technology·
    Yalla Group Concludes Landmark Participation in Saudi eLeague 2026

    DUBAI, UAE, June 8, 2026 /PRNewswire/ -- Yalla Group Limited ("Yalla" or the "Company") (NYSE:YALA), the largest Middle East and North Africa (MENA)-based online social networking and gaming company, today announced the conclusion of its participation in Saudi eLeague 2026 (SEL 2026). As the Official Event Partner of SEL 2026 and Presenting Partner of Yalla Saudi eLeague Women 2026, Yalla Group played an active role throughout the season, reinforcing its long-term commitment to supporting growth and diversity in esports, gaming communities and digital entertainment ecosystems across Saudi Arabia and the wider MENA region. The Yalla Saudi eLeague Women 2026, which ran from February 23 to June

  • Twenty One Capital Inc. logo
    PR··Finance·
    Twenty One Capital Appoints Independent Director to Board

    Appointment restores audit committee compliance with applicable SEC and NYSE independence requirements Twenty One Capital, Inc. ("Twenty One" or "XXI") today announced the appointment of Paul S. Lalljie as an independent director to its Board of Directors. Lalljie will also serve as a member of the Board's audit committee. Lalljie is an accomplished executive and board leader with deep experience across finance, technology, cybersecurity, and education technology. He currently serves as a Member of the Supervisory Board and Audit Committee Chair at Bitdefender. He previously served as Chief Executive Officer and Chief Financial Officer of 2U and as Chief Financial Officer of Neustar. Hi

  • McEwen Inc. logo
    PR··Basic Materials·
    Pre-Feasibility Study for Grey Fox at Fox Complex — High Returns, Manageable Capital, Mine Life Extended to 2041

    TORONTO, June 08, 2026 (GLOBE NEWSWIRE) -- McEwen Inc. (NYSE, (NYSE, TSX:MUX) ("McEwen" or the "Company") is pleased to announce the results of the Pre-Feasibility Study ("PFS") for its 100%-owned Grey Fox Project, located near Timmins, Ontario. Grey Fox is expected to become a major source of ore for the Fox Complex and play a key role in increasing production. With the addition of Grey Fox, gold production at the Fox Complex is projected to reach ~100,000 gold ounces in 2029 and average ~87,000 gold ounces annually from 2028 through 2041. This production growth is expected to support the Company's near-term objective of increasing total annual production to 250,000–300,000 gold equivalen

  • Lyell Immunopharma Inc. logo
    PR··Health Care·
    Lyell Immunopharma Provides Update on Safety Profile of LYL273 in Relapsed or Refractory Metastatic Colorectal Cancer and Amends Phase 1 Trial to Phase 1/2 Expansion

    Gastrointestinal prophylaxis reduced Grade ≥ 2 diarrhea/colitis from 55% without prophylaxis to 10% with prophylaxisThe maximum tolerated dose has not yet been determinedNo difference is observed in GCC CAR T-cell expansion kinetics in patients with or without GI prophylaxisOngoing U.S. Phase 1 trial amended to enable seamless expansion into a potential pivotal single-arm Phase 2 trial pending regulatory alignmentAmendment of ongoing U.S. Phase 1 trial adds new cohorts, including a second-line cohort and a cohort evaluating a combination strategy with radiotherapyAdditional Phase 1 clinical data, including clinical outcomes, and End-of-Phase 1 FDA meeting expected in second half of 2026 SOU

  • Lixiang Education Holding Co. Ltd. logo
    PR··Real Estate·
    Lixiang Education Regains Compliance with Nasdaq Minimum Market Value of Publicly Held Shares Requirement

    LISHUI, China, June 08, 2026 (GLOBE NEWSWIRE) -- Lixiang Education Holding Co., Ltd. (NASDAQ:LXEH), a prestigious private education service provider in China, today announced that on June 5, 2026, it received a letter from the Listing Qualification Department of Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that for at least the 10 consecutive business days, from May 21, 2026 to June 4, 2026, the Company's minimum market value of publicly held shares ("MVPHS") has been US$5,000,000 or greater. Accordingly, the Company has regained compliance with Listing Rule 5450(b)(1)(C), and this matter is now closed. On February 9, 2026, the Company was notified by Nasdaq that its listed se

  • Anteris Technologies Global Corp. logo
    PR··Health Care·
    Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance

    MINNEAPOLIS and BRISBANE, Australia, June 08, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ:AVR, ASX: AVR)) announced today that it has received full regulatory clearance from the French National Agency for Medicines and Health Products Safety (ANSM) for the DurAVR® Transcatheter Heart Valve (THV) global pivotal trial in patients with severe calcific aortic stenosis (the "PARADIGM Trial"). This authorization marks a significant milestone in the Company's clinical and regulatory strategy and enables patient recruitment to commence at leading centers in France. "Securing French regulatory clearance is an important step in the execution of th

  • Shattuck Labs Inc. logo
    PR··Health Care·
    Shattuck Labs Announces Phase 1 Results for SL-325

    Potentially best-in-mechanism immunogenicity profile, with only 3.7% of participants developing antidrug antibodies Complete blockade of TL1A binding to DR3 for over 3 months expected at doses of 1 mg/kg and higherWell tolerated with a favorable safety profile consistent with the TL1A inhibitor classNo evidence of DR3 agonismRECEPTIVE-CD1 Phase 2b clinical trial in patients with Crohn's disease expected to initiate in the third quarter of 2026 Lead bispecific product candidate, SL-846 (DR3xIL-23R), currently being evaluated in IND-enabling toxicology studies; Phase 1 initiation expected in the first half of 2027 AUSTIN, TX and DURHAM, NC, June 08, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, I

  • Enigmatig Limited logo
    PR··Consumer Discretionary·
    Enigmatig Limited Issues Statement on Recent Share Trading Activity

    SINGAPORE, June 08, 2026 (GLOBE NEWSWIRE) -- Enigmatig Limited (NYSE:EGG) ("Enigmatig" or the "Company"), a global business enabler supporting companies expanding across borders, today announced that the Company issued the following statement in accordance with Section 401(d) of the NYSE American Company Guide regarding recent trading activity in its ordinary shares on June 4 and 5, 2026. The Company's general policy is not to comment on unusual market activity or market speculation. The Company confirms that, based on its internal review, it is not aware of any material developments in its business or affairs that have not been previously disclosed, nor is it aware of any other reason th

  • American Battery Technology Company logo
    PR··Basic Materials·
    American Battery Technology Company Wins Appeal and Has US Department of Energy Grant Reinstated for $115 million Project for Commercial Scale Critical Mineral Lithium Refinery

    Reno, Nev., June 08, 2026 (GLOBE NEWSWIRE) -- Reinstatement advances the company's Tonopah Flats Lithium Project – one of the largest identified critical mineral lithium resources in the United States – strengthening domestic battery metals supply chains and national energy security   Advances ABTC's leadership in domestic battery materials while scaling a secure, U.S.-based critical minerals supply chain American Battery Technology Company (NASDAQ:ABAT), an integrated critical mineral manufacturing company that is commercializing its internally-developed technologies for both primary critical minerals manufacturing and secondary critical mineral recycling, announced it has won its a

  • Duluth Holdings Inc. logo
    PR··Consumer Discretionary·
    Duluth Holdings Inc. Announces First Quarter 2026 Financial Results

    Net Income improves by $5.2M and Adjusted EBITDA rises by $6.4M over prior year Gross Margin reaches 57.4%, an expansion of 540 basis points versus prior year Strong balance sheet with approximately $100 million of net liquidity and inventory down 24.8% versus prior year MOUNT HOREB, Wis., June 08, 2026 (GLOBE NEWSWIRE) -- Duluth Holdings Inc. (dba, Duluth Trading Company) ("Duluth Trading" or the "Company") (NASDAQ:DLTH), a lifestyle brand of men's and women's workwear, casual wear, outdoor apparel and accessories, today announced its financial results for the fiscal First Quarter ended May 3, 2026. Summary of the First Quarter ended May 3, 2026 Net loss of $10.0 million compared to

  • GEN Restaurant Group Inc. logo
    PR··Consumer Discretionary·
    GEN Restaurant Group Secures Retail Placement at Save Mart Supermarkets with Six SKU Launch

    CERRITOS, Calif., June 08, 2026 (GLOBE NEWSWIRE) -- GEN Restaurant Group, Inc. ("GEN" or the "Company") (NASDAQ:GENK), operator of GEN Korean BBQ, one of the largest full-service Korean BBQ restaurant chains in the United States, today announced that its consumer packaged goods products have been accepted for retail placement at Save Mart Supermarkets, a leading regional grocery chain across California and Nevada. GEN will launch six SKUs across all Save Mart store locations, with each location initially stocking one case per SKU. Founded in Modesto, California in 1952, The Save Mart Companies is the largest regional grocer in California, operating nearly 200 stores across California and

  • Pony AI Inc. logo
    PR··Technology·
    Pony AI Inc. Announces Results of the Annual General Meeting

    GUANGZHOU, China, June 8, 2026 /PRNewswire/ -- Pony AI Inc. ("Pony.ai" or the "Company") (NASDAQ:PONY, HKEX: 2026)), a global leader in achieving large-scale mass production and commercialization of autonomous driving technology, today announced that each of the proposed resolutions submitted for shareholders' approval (the "Proposed Resolutions") as set forth in the notice of the annual general meeting dated April 22, 2026, Hong Kong time (the "AGM Notice"), has been adopted at the annual general meeting held in Guangzhou, China today. After the adoption of the Proposed Resolutions, all corporate authorizations and actions contemplated thereunder are approved, including, among other things,

  • Haleon plc logo
    PR··Consumer Discretionary·
    Haleon Invests in India to Deliver Better Everyday Health to Rural Communities

    £175m for first Haleon manufacturing site in Madhya Pradesh, central India Fast-growing India key to Haleon reaching one billion more consumers by 2030 India's consumer health market to reach over £23bn by 20301 Accelerated rural distribution to access 3 million outlets Affordable Sensodyne packs and investment to double ‘last-mile' reach in rural areas Haleon, a consumer company that is solely focused on better everyday health, today announces plans to expand its business in India, one of its fastest-growing markets and key to Haleon delivering its strategy and ambitions to reach one billion more consumers by 2030. Haleon will invest approximately £175 million2 in building

  • Yiren Digital Ltd. logo
    PR··Finance·
    Yiren Digital Announces Increase in Beneficial Ownership by Mr. Ning Tang Following Controlling Shareholder Restructuring

    BEIJING, June 8, 2026 /PRNewswire/ -- Yiren Digital Ltd. (NYSE:YRD) ("Yiren Digital" or the "Company"), a leading fintech company specializing in digital consumer lending, insurance and financial technology innovation across China and global markets, today announced that it has been notified by CreditEase Holdings (Cayman) Limited, the Company's controlling shareholder (the "Controlling Shareholder"), that a change in the Controlling Shareholder's shareholding structure took place on June 5, 2026 (the "Restructuring"). As a result of the Restructuring, Mr. Ning Tang, the Company's Executive Chairman and Chief Executive Officer, now beneficially owns the entire equity interests in the Control

  • Advanced Micro Devices Inc. logo
    PR··Technology·
    AMD Commits up to £2 Billion to Accelerate AI Innovation and Research in the United Kingdom

    News Highlights: £2bn investment over five years to support advanced computing, scientific research and workforce development across the United Kingdom.New strategic partnerships with Imperial College London and Oriole Networks will help advance AI, quantum and next-generation computing research.AMD and Dell Technologies are supporting the University of Cambridge's Zenith AI supercomputer and Sunrise fusion AI system, helping expand the UK's sovereign AI infrastructure.AMD Instinct™ GPUs, AMD EPYC™ CPUs and AMD ROCm™ open software will support projects spanning scientific research, healthcare, public-sector innovation and AI-driven discovery. LONDON, June 08, 2026 (GLOBE NEWSWIRE) -- AMD

  • Alvotech logo
    PR··Health Care·
    Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio®

    REYKJAVIK, Iceland, June 08, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ:ALVO, ALVO-SDB)), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for AVT16, a proposed interchangeable biosimilar to Entyvio® (vedolizumab) lyophilized vial for intravenous administration. Under a partnership with Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), Alvotech is responsible for development and manufacturing of AVT16, while Teva is responsible for commercialization. "FDA acceptance of the BLA f